New Trial Offers Hope for Endometriosis Sufferers

A groundbreaking £2.3 million study is offering new hope to millions of women suffering from endometriosis, a debilitating condition that causes chronic pain. The UK-wide trial, led by the University of Aberdeen and NHS Grampian, aims to determine if a personalized pain management program can significantly improve the quality of life for those affected.

Charlotte McCann, 27, has lived with stage 4 endometriosis since she was 14, experiencing severe pain that led her to abandon a career in corporate finance. She described waking up at night with vomiting and being unable to stand or get out of bed on some days. "The pain would come on so strong, I wouldn't be able to even sit up straight, I wouldn't be able to stand up," McCann said. "It was heavily disrupting my life. I couldn't focus on anything, and I couldn't sleep or eat because of the pain."

Endometriosis is a systemic inflammatory disease where cells similar to the lining of the womb grow in other parts of the body, such as the bowel or lungs. This can lead to years of delayed diagnosis and intense pain, with no known cure. McCann has undergone surgery to remove affected tissue, but her symptoms returned. She is currently on strong opioid painkillers, which cause nausea and weight loss, and sometimes requires walking aids.

"Endometriosis has had a huge impact on my life, and I am delighted to hear that they are looking at new ways to help the millions of women who are suffering with this every single day," McCann stated.

What the Trial Involves

The five-year study, funded by the National Institute for Health and Care Research (NIHR), will involve a 12-week personalized program called an endometriosis-specific pain management program (e-PMP). This program integrates psychotherapy informed by cognitive behavioral therapy (CBT), specialist physiotherapy, guidance on relationships and communication, and medication to manage side effects.

Participants will be recruited by specialists. Pre-menopausal women will either receive the e-PMP alongside standard care or standard care alone, with the outcomes of both approaches being compared. The goal is to evaluate if this strategy offers more effective treatment for women whose pain is not adequately managed by surgery or medication.

Dr. Lucky Saraswat, a consultant gynecologist and lead for the Aberdeen Endometriosis Centre at NHS Grampian, is heading the study. "Endometriosis is one of the most common yet under researched causes of chronic pain," she said. "Many women continue to suffer even after surgery or medication. This study will help us understand whether a tailored, interdisciplinary pain management programme can offer meaningful, long term improvements in quality of life."

Saraswat added that if effective, e-PMP could become a vital new treatment option, especially for women seeking alternatives to repeated surgery or hormonal therapies, or those planning a pregnancy.

Potential to Revolutionize Care

Prof. Anthony Gordon, director of NIHR's health technology assessment program, highlighted the long periods of suffering many women endure with limited options. "High-quality research is essential to break this cycle and deliver treatment that addresses the full, complex impact of endometriosis," he said. "By evaluating tailored, non-surgical pain management, this trial could revolutionise care – providing desperately needed support, improving daily lives, and offering long-term relief when standard treatments haven't worked."

Emma Cox, chief executive of Endometriosis UK, welcomed the research, stating, "Symptoms of endometriosis including chronic pelvic pain can have a significant impact on someone's physical and mental health, and research is vital to helping improve management and treatment options. We welcome this much-needed research and look forward to working with the team to see how an endometriosis specific pain management programme could support those with the disease in the future."

The study will also assess the cost-effectiveness of the new approach. Initial work for the trial has already begun, with participant recruitment to follow.